CaroGen Corporation
Farmington, US · 1 known investors
CaroGen develops immunotherapies for cancer treatment, including the CARG-2020 platform for ovarian and colorectal cancer, and is partnering with the NIH on a universal influenza vaccine.
BiotechHealthtech
Investors · 1
In the news
- CaroGen’s Hepatitis B vaccine recommended for $6.8M in federal fundinghartfordbusiness.com · 2022
- CaroGen Corporation Raises $150K in Funding - FinSMEsfinsmes.com · 2013